stella
beta
Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator — Stella
Recruiting
Back to Cardiogenic Shock trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(2 sites)
South Korea
Samsung Medical Center, Seoul
Samsung Medical Center, Seoul
View full record on ClinicalTrials.gov